T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis

Journal of Biological Chemistry

Volumn 287, Issue 44, 2012, Pages 36720-36731

  Rogers, Heather ^a   Wang, Li ^a   Yu, Xiaobing ^a,g   Alnaeeli, Mawadda ^a   Cui, Kairong ^b   Zhao, Keji ^b   Bieker, James J ^c   Prchal, Josef ^d   Huang, Suming ^e   Weksler, Babette ^f   Noguchi, Constance Tom ^a  

^a NIDDK   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION COMPLEX; ACUTE LEUKEMIA; ERYTHROPOIETIN (EPO); ERYTHROPOIETIN RECEPTORS; MOLECULAR LINKS;

BIOCHEMISTRY; BIOLOGY;

GENE EXPRESSION;

ERYTHROPOIETIN RECEPTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR TAL1;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME REGULATION; EPO R GENE; ERYTHROCYTOSIS; GENE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; NUCLEOSOME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; TAL1 GENE; TRANSCRIPTION INITIATION SITE;

ADULT; ANTIGENS, CD; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BETA-GLOBINS; BINDING SITES; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; ERYTHROID CELLS; ERYTHROPOIETIN; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES, RENILLA; MALE; MUTATION, MISSENSE; POLYCYTHEMIA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTORS, ERYTHROPOIETIN;

EID: 84868228743     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.378398     Document Type: Article

References (52)

1. Wu, H., Liu, X., Jaenisch, R., and Lodish, H. F. (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67
2. Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990
3. Percy, M. J., Furlow, P. W., Lucas, G. S., Li, X., Lappin, T. R., McMullin, M. F., and Lee, F. S. (2008)Again-of-function mutation in the HIF2A gene in familial erythrocytosis. N. Engl. J. Med. 358, 162-168
4. Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., Maxwell, P. H., Stockton, D. W., Semenza, G. L., and Prchal, J. T. (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32, 614-621
5. Percy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R., Maxwell, P. H., McMullin, M. F., and Lee, F. S. (2006) A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. U.S.A. 103, 654-659
6. Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., Scott, M. A., Erber, W. N., and Green, A. R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365, 1054-1061
7. Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., Warren, A. J., Gilliland, D. G., Lodish, H. F., and Green, A. R. (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N. Engl. J. Med. 356, 459-468
8. Meyer, L., Deau, B., Forejtníková, H., Duménil, D., Margottin-Goguet, F., Lacombe, C., Mayeux, P., and Verdier, F. (2007) β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109, 5215-5222
9. Agarwal, N., Gordeuk, R. V., and Prchal, J. T. (2007) Genetic mechanisms underlying regulation of hemoglobin mass. Adv. Exp. Med. Biol. 618, 195-210
10. Arcasoy, M. O., Harris, K. W., and Forget, B. G. (1999) A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Exp. Hematol. 27, 63-74
11. Rogers, H. M., Yu, X., Wen, J., Smith, R., Fibach, E., and Noguchi, C. T. (2008) Hypoxia alters progression of the erythroid program. Exp. Hematol. 36, 17-27
12. Pope, N. J., and Bresnick, E. H. (2010) Differential coregulator requirements for function of the hematopoietic transcription factor GATA-1 at endogenous loci. Nucleic Acids Res. 38, 2190-2200
13. Hu, X., Ybarra, R., Qiu, Y., Bungert, J., and Huang, S. (2009) Transcriptional regulation by TAL1. A link between epigenetic modifications and erythropoiesis. Epigenetics 4, 357-361
14. Ravet, E., Reynaud, D., Titeux, M., Izac, B., Fichelson, S., Roméo, P. H., Dubart-Kupperschmitt, A., and Pflumio, F. (2004) Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood 103, 3326-3335
15. Kassouf, M. T., Chagraoui, H., Vyas, P., and Porcher, C. (2008) Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis. Blood 112, 1056-1067
16. Schuh, A. H., Tipping, A. J., Clark, A. J., Hamlett, I., Guyot, B., Iborra, F. J., Rodriguez, P., Strouboulis, J., Enver, T., Vyas, P., and Porcher, C. (2005) ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol. 25, 10235-10250
17. Meier, N., Krpic, S., Rodriguez, P., Strouboulis, J., Monti, M., Krijgsveld, J., Gering, M., Patient, R., Hostert, A., and Grosveld, F. (2006) Novel binding partners of Ldb1 are required for haematopoietic development. Development 133, 4913-4923
18. Huang, S., Qiu, Y., Shi, Y., Xu, Z., and Brandt, S. J. (2000) P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J. 19, 6792-6803
19. Hu, X., Li, X., Valverde, K., Fu, X., Noguchi, C., Qiu, Y., and Huang, S. (2009) LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 106, 10141-10146
20. Huang, S., and Brandt, S. J. (2000) mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol. Cell. Biol. 20, 2248-2259
21. Tripic, T., Deng, W., Cheng, Y., Zhang, Y., Vakoc, C. R., Gregory, G. D., Hardison, R. C., and Blobel, G. A. (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113, 2191-2201
22. Yu, M., Riva, L., Xie, H., Schindler, Y., Moran, T. B., Cheng, Y., Yu, D., Hardison, R., Weiss, M. J., Orkin, S. H., Bernstein, B. E., Fraenkel, E., and Cantor, A. B. (2009) Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell 36, 682-695
23. Wilson, N. K., Miranda-Saavedra, D., Kinston, S., Bonadies, N., Foster, S. D., Calero-Nieto, F., Dawson, M. A., Donaldson, I. J., Dumon, S., Frampton, J., Janky, R., Sun, X. H., Teichmann, S. A., Bannister, A. J., and Göttgens, B. (2009) The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood 113, 5456-5465
24. Fujiwara, T., O'Geen, H., Keles, S., Blahnik, K., Linnemann, A. K., Kang, Y. A., Choi, K., Farnham, P. J., and Bresnick, E. H. (2009) Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36, 667-681
25. Vyas, P., McDevitt, M. A., Cantor, A. B., Katz, S. G., Fujiwara, Y., and Orkin, S. H. (1999) Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126, 2799-2811
26. Chin, K., Oda, N., Shen, K., and Noguchi, C. T. (1995) Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res. 23, 3041-3049
27. Fibach, E. (1998) Techniques for studying stimulation of fetal hemoglobin production in human erythroid cultures. Hemoglobin 22, 445-458
28. Fernández, L. A., Winkler, M., and Grosschedl, R. (2001) Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol. Cell. Biol. 21, 196-208
29. Aplan, P. D., Lombardi, D. P., Reaman, G. H., Sather, H. N., Hammond, G. D., and Kirsch, I. R. (1992) Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79, 1327-1333
30. Chepelev, I., Wei, G., Tang, Q., and Zhao, K. (2009) Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq. Nucleic Acids Res. 37, e106
31. Schones, D. E., Cui, K., Cuddapah, S., Roh, T. Y., Barski, A., Wang, Z., Wei, G., and Zhao, K. (2008) Dynamic regulation of nucleosome positioning in the human genome. Cell 132, 887-898
32. Nussenzveig, R. H., Swierczek, S. I., Jelinek, J., Gaikwad, A., Liu, E., Verstovsek, S., Prchal, J. F., and Prchal, J. T. (2007) Polycythemia vera is not initiated by JAK2V617F mutation. Exp. Hematol. 35, 32-38
33. Aplan, P. D. (2006) Causes of oncogenic chromosomal translocation. Trends Genet. 22, 46-55
34. Bockamp, E. O., McLaughlin, F., Göttgens, B., Murrell, A. M., Elefanty, A. G., and Green, A. R. (1997) Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells. J. Biol. Chem. 272, 8781-8790
35. Göttgens, B., Nastos, A., Kinston, S., Piltz, S., Delabesse, E. C., Stanley, M., Sanchez, M. J., Ciau-Uitz, A., Patient, R., and Green, A. R. (2002) Establishing the transcriptional programme for blood. The SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J. 21, 3039-3050
36. Delabesse, E., Ogilvy, S., Chapman, M. A., Piltz, S. G., Gottgens, B., and Green, A. R. (2005) Transcriptional regulation of the SCL locus. Identification of an enhancer that targets the primitive erythroid lineage in vivo. Mol. Cell. Biol. 25, 5215-5225
37. Sengupta, T., Cohet, N., Morlé, F., and Bieker, J. J. (2009) Distinct modes of gene regulation by a cell-specific transcriptional activator. Proc. Natl. Acad. Sci. U.S.A. 106, 4213-4218
38. Noguchi, C. T., Bae, K. S., Chin, K., Wada, Y., Schechter, A. N., and Hankins, W. D. (1991) Cloning of the human erythropoietin receptor gene. Blood 78, 2548-2556
39. Zon, L. I., Youssoufian, H., Mather, C., Lodish, H. F., and Orkin, S. H. (1991) Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc. Natl. Acad. Sci. U.S.A. 88, 10638-10641
40. Wang, L., Jia, Y., Rogers, H., Wu, Y. P., Huang, S., and Noguchi, C. T. (2012) GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1). J. Biol. Chem. 287, 30157-30169
41. Kassouf, M. T., Hughes, J. R., Taylor, S., McGowan, S. J., Soneji, S., Green, A. L., Vyas, P., and Porcher, C. (2010) Genome-wide identification of TAL1's functional targets. Insights into its mechanisms of action in primary erythroid cells. Genome Res. 20, 1064-1083
42. Ismailoglu, I., Yeamans, G., Daley, G. Q., Perlingeiro, R. C., and Kyba, M. (2008) Mesodermal patterning activity of SCL. Exp. Hematol. 36, 1593-1603
43. Yamada, Y., Warren, A. J., Dobson, C., Forster, A., Pannell, R., and Rabbitts, T. H. (1998) The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 95, 3890-3895
44. Hu, G., Schones, D. E., Cui, K., Ybarra, R., Northrup, D., Tang, Q., Gattinoni, L., Restifo, N. P., Huang, S., and Zhao, K. (2011) Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res. 21, 1650-1658
45. Hall, M. A., Slater, N. J., Begley, C. G., Salmon, J. M., Van Stekelenburg, L. J., McCormack, M. P., Jane, S. M., and Curtis, D. J. (2005) Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene. Mol. Cell. Biol. 25, 6355-6362
46. Cheng, Y., Wu, W., Kumar, S. A., Yu, D., Deng, W., Tripic, T., King, D. C., Chen, K. B., Zhang, Y., Drautz, D., Giardine, B., Schuster, S. C., Miller, W., Chiaromonte, F., Zhang, Y., Blobel, G. A., Weiss, M. J., and Hardison, R. C. (2009) Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res. 19, 2172-2184
47. Xu, Z., Huang, S., Chang, L. S., Agulnick, A. D., and Brandt, S. J. (2003) Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol. Cell. Biol. 23, 7585-7599
48. Song, S. H., Hou, C., and Dean, A. (2007) A positive role for NLI/Ldb1 in long-range β-globin locus control region function. Mol. Cell 28, 810-822
49. Anderson, K. P., Crable, S. C., and Lingrel, J. B. (2000) The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression. Blood 95, 1652-1655
50. Elefanty, A. G., Robb, L., Birner, R., and Begley, C. G. (1997) Hematopoietic- pecific genes are not induced during in vitro differentiation of sclnull embryonic stem cells. Blood 90, 1435-1447
51. Russell, L. J., De Castro, D. G., Griffiths, M., Telford, N., Bernard, O., Panzer-Grümayer, R., Heidenreich, O., Moorman, A. V., and Harrison, C. J. (2009) A novel translocation, t(14;19)(q32;p13), involving IGHα and the cytokine receptor for erythropoietin. Leukemia 23, 614-617
52. Fine, B. M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S., Harbott, J., and Boxer, L. M. (2004) Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 103, 1043-1049